Repligen Corp (RGEN)

Oct 01, 2026

Continuous Bioprocessing Technologies Market - GlobeNewswire Inc.

Oct 01, 2026

Sep 30, 2026

Repligen Corporation (RGEN) Stock Price, News, Quote & History - Yahoo! Finance Canada

Sep 30, 2026

Sep 29, 2026

Repligen stock price target reaffirmed at $225 by UBS on growth outlook - Investing.com South Africa

Sep 29, 2026

Sep 29, 2026

Why Did KOD, RGEN, BIIB Stocks Rise To 52-Week Highs? - TradingView

Sep 29, 2026

Sep 28, 2026

Form 4 Repligen Corporation For: 28 September - Investing.com India

Sep 28, 2026

Sep 28, 2026

After a stock-unit release, Repligen (RGEN) withheld 421 shares from its CFO to cover taxes. - Stock Titan

Sep 28, 2026

Sep 27, 2026

Repligen CEO Olivier Loeillot sells $976,680 in company stock By Investing.com - Investing.com South Africa

Sep 27, 2026

Sep 27, 2026

Form 4 Repligen Corporation For: 27 September By Investing.com - Investing.com Canada

Sep 27, 2026

Sep 27, 2026

Repligen CEO Olivier Loeillot sells $976,680 in company stock - Investing.com

Sep 27, 2026

Sep 27, 2026

Form 4 Repligen Corporation For: 27 September - Investing.com India

Sep 27, 2026

Sep 27, 2026

Repligen Corporation (RGEN) stock price, news, quote and history - Yahoo Finance UK

Sep 27, 2026

Sep 26, 2026

US759916AC3 Bond Profile: Coupon and Redemption - TradingView

Sep 26, 2026

Sep 26, 2026

Repligen CEO Loeillot sells $2.46m in shares By Investing.com - Investing.com South Africa

Sep 26, 2026

Sep 26, 2026

Form 4 Repligen Corporation For: 26 September By Investing.com - Investing.com India

Sep 26, 2026

Sep 26, 2026

Repligen CEO Loeillot sells $2.46m in shares - Investing.com

Sep 26, 2026

Sep 25, 2026

Repligen Corp (RGEN) CEO Olivier Loeillot Sells 12,946 Shares - GuruFocus

Sep 25, 2026

Sep 25, 2026

Repligen Stock Price Forecast. Should You Buy RGEN? - StockInvest.us

Sep 25, 2026

Sep 25, 2026

Repligen (RGEN) CEO sells shares at $190 each after exercising options under a trading plan. - Stock Titan

Sep 25, 2026

Sep 24, 2026

Form 144 REPLIGEN CORP For: 24 September By Investing.com - Investing.com Nigeria

Sep 24, 2026

Sep 24, 2026

Repligen Corporation (RGEN) Stock Forecasts - Yahoo Finance

Sep 24, 2026

Sep 24, 2026

Is Repligen Corp (RGEN) Overvalued After 3.3% Rally? GF Value Sa - GuruFocus

Sep 24, 2026

Sep 24, 2026

Shares valued at $2.46 million are listed for sale by a Repligen (NASDAQ: RGEN) officer and director. - Stock Titan

Sep 24, 2026

Sep 24, 2026

Repligen Corp Stock Baskets - GuruFocus

Sep 24, 2026

Sep 23, 2026

Repligen Corp (BSP:R2GE34) Stock Price & 30 Year Financial Data - GuruFocus

Sep 23, 2026

Sep 23, 2026

Repligen Corporation stock hits 52-week high at 188.95 USD - Investing.com

Sep 23, 2026

Sep 23, 2026

Repligen Corp (RGEN) CEO Olivier Loeillot Sells 5,426 Shares - gurufocus.com

Sep 23, 2026

Sep 22, 2026

Repligen Corp (RGEN) Stock Up 3.3% but GF Value Says Overvalued -- GF Score: 87/100 - gurufocus.com

Sep 22, 2026

Sep 22, 2026

Repligen (RGEN) CEO sells 5,426 shares under plan - Stock Titan

Sep 22, 2026

Sep 22, 2026

Biolife Solutions stock hits 52-week high at $38.10 By Investing.com - Investing.com Canada

Sep 22, 2026

Sep 22, 2026

Alkermes Posts Positive Data From Phase I ADHD Study on ALKS 7290 - Zacks Investment Research

Sep 22, 2026

Sep 21, 2026

Repligen (NASDAQ: RGEN) insider plans new stock sale after two recent trades - Stock Titan

Sep 21, 2026

Sep 16, 2026

Repligen (NASDAQ: RGEN) Director Karen Dawes to Step Down on September 30, 2026 - Kalkine Media

Sep 16, 2026

Sep 15, 2026

Karen A. Dawes to Retire from Repligen Board Effective Sept 30, 2026 - TradingView

Sep 15, 2026

Sep 11, 2026

Could Pricing Pressure Change the Repligen (NASDAQ:RGEN) Story? - Kalkine Media

Sep 11, 2026

Sep 10, 2026

BioLife Solutions merger with Repligen advances as antitrust waiting period ends - Investing.com

Sep 10, 2026

Sep 09, 2026

BioLife Solutions' HSR Antitrust Waiting Period Ends Ahead of Repligen Merger - Kalkine Media

Sep 09, 2026

Sep 09, 2026

Repligen at Wells Fargo conference: growth broadens beyond headwinds - Investing.com

Sep 09, 2026

Sep 09, 2026

REPLIGEN CEO Loeillot Olivier Forfeits 2,842 Shares at $169.61 and Sells 3,035 Shares at $165.90 (NASDAQ: RGEN) - Kalkine Media

Sep 09, 2026

Sep 09, 2026

UBS Adjusts Price Target on Repligen to $225 From $195, Keeps Buy Rating - Yahoo Finance

Sep 09, 2026

Sep 08, 2026

Repligen to acquire BioLife for $11.25 cash plus 0.1442 shares per BioLife share; HSR waiting period expired - TradingView

Sep 08, 2026

Sep 08, 2026

[425] REPLIGEN CORP Business Combination Communication | RGEN SEC FilingForm 425 - Stock Titan

Sep 08, 2026

Sep 08, 2026

Repligen (RGEN) CEO trades stock in preset plan - Stock Titan

Sep 08, 2026

Sep 08, 2026

Repligen (NASDAQ: RGEN) Schedules October 5 Vote for BioLife Merger Approval - Kalkine Media

Sep 08, 2026

Sep 08, 2026

REPLIGEN CORP SEC Filing (Sep 8, 2026) - Stock Titan

Sep 08, 2026

Sep 07, 2026

ZimVie Inc. When-Issued (ZIMVV) Peer Comparison – Compare with Others - Value Research

Sep 07, 2026

Sep 05, 2026

Repligen Corp (NASDAQ:RGEN) Combines Strong Growth with a Constructive Technical Setup - ChartMill

Sep 05, 2026

Sep 04, 2026

Repligen Corporation (RGEN) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research

Sep 04, 2026

Sep 04, 2026

Repligen (RGEN) holder lines up new sale after $976K trade - Stock Titan

Sep 04, 2026

Sep 04, 2026

Heska Corporation (HSKA) Peer Comparison – Compare with Others - Value Research

Sep 04, 2026

Sep 04, 2026

What Repligen (NASDAQ: RGEN) plans to pay for each BioLife share - Stock Titan

Sep 04, 2026

Sep 04, 2026

Repligen (RGEN) Stock Looks Near Fair Value After Recent Rebound - Yahoo Finance

Sep 04, 2026

Sep 03, 2026

Repligen Offers Differentiated Solutions as a Leading Bioprocessing Supplier - Morningstar

Sep 03, 2026

Sep 02, 2026

Codex DNA Inc (DNAY) Peer Comparison – Compare with Others - Value Research

Sep 02, 2026

Sep 02, 2026

Repligen (NASDAQ: RGEN) awards 2,466 stock units to its chief accounting officer - Stock Titan

Sep 02, 2026